Phase Dual escalation 3 Weeks 21-24 Tirzepatide 12.5 mg/week Cagrilintide 1.7 mg/week Notes Approach maintenance
Our state-of-the-art facilities, managed by certified professionals, ensure accurate and timely reports for every patient
Khavinson VK
Customer Experiences: Testimonials and Reviews What Are Real Users Saying About Healthletic's BPC-157
MDSC targeting with immune checkpoint blockade Immune checkpoint blockade (ICB) has been a promising avenue in immunotherapy in recent years
Disclosure of interest: Nothing to disclose Poster Session II - PRE-HOSPITAL SERVICE ORGANISATION 09.00 - PRE-HOSPITAL SERVICE ORGANISATION - 09.01 - PRE-HOSPITAL SERVICE ORGANISATION P796 - ESOC25-2094 ASSOCIATION OF PREHOSPITAL CARE INTERVALS AND RECEIPT OF IV THROMBOLYSIS AND ENDOVASCULAR THERAPY IN THE GET WITH THE GUIDELINES-STROKE REGISTRY Regina Royan 1 , Jie Lena Sun 2 , Brooke Alhanti 2 , Brian Stamm 1 , Shyam Prabhakaran 3 , Brian Mac Grory 2 , Adam de Havenon 4 , Christopher Richards 5 , Christine Brent 1 , Kori Zachrison 6 , Amar Dhand 7 , Eric Smith 8 , John Adam Oostema 9 , Mathew Reeves 9 , William Meurer 1 , Gregg Fonarow 10 , Steven R Mess 11 , Kevin Sheth 4 1 University of Michigan, Ann Arbor, United States, 2 Duke University, Durham, United States, 3 University of Chicago, Chicago, United States, 4 Yale University, New Haven, United States, 5 University of Cincinnati, Cincinnati, United States, 6 Massachusetts General Hospital, Boston, United States, 7 Brigham and Women's Hospital, Boston, United States, 8 University of Calgary, Calgary, United States, 9 Michigan State University, Lansing, United States, 10 University of California Los Angeles, Los Angeles, United States, 11 University of Pennsylvania, Philadelphia, United States Background and Aims: There is limited understanding of the association between prehospital care intervals and receipt of stroke reperfusion including thrombolysis and endovascular therapy (EVT)
